Clinical & Experimental Immunology · 2018 · 54 citations · 27 references
Life SciencesImmunologyPathobiologyAutoimmunityInflammationRheumatologyAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune InflammationInflammatory SignalingNeutrophil BiologyRheumatoid ArthritisNeutrophil MigrationPhosphatidylinositol 3-Kinase Akt SignalingPhosphatidylinositol 3-Kinase-akt SignalingReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction AssaysWestern Blot Analysis
Our previous study revealed that Yin Yang 1(YY1) played an important part in promoting interleukin (IL)-6 production in rheumatoid arthritis (RA). However, whether YY1 has any role in regulation of IL-8 in RA remains unclear. YY1 and IL-8 expression in RA patients were analyzed by real-time polymerase chain reaction (PCR). Ingenuity pathway analysis (IPA) was used to analyze the signaling pathway involved in YY1-induced IL-8 production. The expression of YY1 and proteins involved in the pathway were detected by Western blot and enzyme-linked immunosorbent assay (ELISA). Migration of neutrophils was performed by chemotaxis assay. In this study, we found that high expression of IL-8 was positively associated with YY1 expression in RA. Blocking YY1 expression by YY1-short hairpin (sh)RNA lentivirus reduced IL-8 production. Mechanistically, we showed YY1 activated IL-8 production via the phosphatidylinositol-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway. Further, using a co-culture system consisting of peripheral blood mononuclear cells (PBMC) and neutrophils, we found that migration of neutrophils would be inhibited by YY1 RNA interference. Finally, using the collagen-induced arthritis animal model, we showed that treatment with the YY1-shRNA lentivirus led to reduction of IL-8 levels and attenuation of inflammation and neutrophil infiltration in vivo. Our results reveal a role of YY1 involved in neutrophil infiltration in RA via the PI3K/Akt/mTOR/IL-8 signaling pathway. YY1 may be a new therapeutic target for treatment of RA.
27
Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text
Medicine, Internal Medicine, Clinical Classification Systems +13
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart, Giuseppina Costantino, Marko Poglitsch et al. · Immunity · 2008 · 802 citations · Full text
IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway
Dung‐Fang Lee, Hsu-Ping Kuo, Chun‐Te Chen et al. · Cell · 2007 · 630 citations · Full text
Medicine, Cancer Biology, Oncology +17